These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 25436304)
1. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma. Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304 [TBL] [Abstract][Full Text] [Related]
2. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma]. Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Wang B; Xu T; Liu J; Zang S; Gao L; Huang A Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114 [TBL] [Abstract][Full Text] [Related]
4. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669 [TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576 [TBL] [Abstract][Full Text] [Related]
8. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000 [TBL] [Abstract][Full Text] [Related]
9. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis. Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581 [TBL] [Abstract][Full Text] [Related]
10. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
13. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma. Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays. Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386 [TBL] [Abstract][Full Text] [Related]
16. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma. Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948 [TBL] [Abstract][Full Text] [Related]
17. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival. Li T; Yin J; Yuan L; Wang S; Yang L; Du X; Lu J Oncol Rep; 2014 Apr; 31(4):1699-706. PubMed ID: 24549282 [TBL] [Abstract][Full Text] [Related]
19. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
20. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]